![](/img/cover-not-exists.png)
Ragaglitazar: The Pharmacokinetics, Pharmacodynamics, and Tolerability of a Novel Dual PPARα and γ Agonist in Healthy Subjects and Patients with Type 2 Diabetes
Skrumsager, B. K., Nielsen, K. K., Müller, M., Pabst, G., Drake, P. G., Edsberg, B.Volume:
43
Langue:
english
Journal:
The Journal of Clinical Pharmacology
DOI:
10.1177/0091270003257230
Date:
November, 2003
Fichier:
PDF, 193 KB
english, 2003